Cargando…
[Translated article] Practical Guide to New Treatments for SARS-CoV-2 Infection in Dermatology Patients Being Treated With Common Immunomodulators
Immunosuppressants and immunomodulators are widely used in dermatology. Some of these drugs, however, can increase the risk of severe COVID-19. New antivirals against SARS-CoV-2 have been shown to reduce progression to COVID-19 pneumonia in susceptible patients, but their availability is limited. On...
Autores principales: | Viedma-Martínez, M., Gallo-Pineda, G., Jiménez-Gallo, D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AEDV. Published by Elsevier España, S.L.U.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9642030/ http://dx.doi.org/10.1016/j.ad.2022.07.024 |
Ejemplares similares
-
[Translated article] Hydroxychloroquine: An Essential Drug in Dermatology and Its Controversial Use in COVID-19()
por: Morgado-Carrasco, D., et al.
Publicado: (2022) -
Practice Efficiency in Dermatology: Enhancing Quality of Care and Physician Well-Being
por: Katta, Rajani, et al.
Publicado: (2023) -
[Translated article] Facial Vitiligo After SARS-CoV-2 Vaccination
por: Flores-Terry, M.Á., et al.
Publicado: (2022) -
Dermatological Manifestations in Patients With SARS-CoV-2: A Systematic Review
por: Almutairi, Abdulelah, et al.
Publicado: (2020) -
Dermatology
Publicado: (1892)